{"id":129454,"date":"2024-07-25T15:07:30","date_gmt":"2024-07-25T09:37:30","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=129454"},"modified":"2024-07-25T15:12:56","modified_gmt":"2024-07-25T09:42:56","slug":"pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/","title":{"rendered":"Pharma stock jumps after it announces stock split and JV with Nestle"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3739584950\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Share price of a leading pharmaceutical company rose by nearly 1 percent following its announcement of plans for a stock split and a joint venture with Nestle.\u00a0<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1713629163\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Price movement<\/strong><strong>&nbsp;<\/strong><\/h2><p>In Thursday\u2019s trading session, the share price of <strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/DRREDDY\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Dr. Reddy\u2019s Laboratories Ltd.<\/a><\/strong> reached an intra-day high of Rs.6,853 per share gaining nearly 1 percent after opening at Rs.6,795 apiece. The share price has delivered a return of more than 23 percent in a year.\u00a0<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Stock split<\/strong><strong>&nbsp;<\/strong><\/h2><p>Hyderabad-based pharmaceutical company Dr. Reddy\u2019s Laboratories Ltd. announced on Wednesday that its Board of Directors will meet on July 27, 2024, at the company&#8217;s registered office to consider the <strong>sub-division (split) of the<\/strong><strong> <\/strong><strong>company&#8217;s equity shares having a face value of Rs.5 each<\/strong>.&nbsp;<\/p><p>This marks the first instance of a stock split for the company since it became public. The last stock split occurred in October 2001, when the face value was changed from Rs.10 to Rs.5.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-174089755\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Joint Venture and ownership<\/strong><strong>&nbsp;<\/strong><\/h2><p>Dr. Reddy&#8217;s Laboratories Ltd. and Nestle India Ltd. have officially launched a joint venture named <strong>Dr. Reddy\u2019s and Nestle Health Science Ltd.&nbsp;<\/strong><\/p><p>Following the joint venture agreement, Dr. Reddy\u2019s Laboratories has transferred 49 percent of the equity share capital in the joint venture to Nestl\u00e9 India. As a result, Dr. Reddy\u2019s Laboratories now retains 51 percent of the share capital, consisting of 51,000 equity shares with a face value of Rs.10 each, while Nestl\u00e9 India Limited holds 49 percent, comprising 49,000 equity shares of Rs.10 each in the joint venture company.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Dr. Reddy\u2019s and Nestle Health Science Ltd.&nbsp;<\/strong><\/h2><p>The joint venture, Dr. Reddy\u2019s and Nestl\u00e9 Health Science Ltd., aims to introduce cutting-edge nutraceutical brands to consumers in India and other designated regions, harnessing the combined capabilities of both organizations.&nbsp;<\/p><p>Nestl\u00e9 India will bring its renowned global portfolio of nutritional health solutions, including vitamins, minerals, herbals, and supplements from Nestl\u00e9 Health Science, complemented by Dr. Reddy&#8217;s robust commercial presence across India.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Also read<\/strong><\/p><\/blockquote><figure class=\"wp-block-embed is-type-wp-embed is-provider-trade-brains wp-block-embed-trade-brains\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\" data-secret=\"otBllmPg3H\"><a href=\"https:\/\/tradebrains.in\/features\/block-deal-bank-stock-falls-4-after-7-9-stake-worth-1100-cr-changed-hands\/\">Block Deal: Bank stock falls 4% after 7.9% stake worth \u20b9 1,100 Cr changed hands<\/a><\/blockquote><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"&#8220;Block Deal: Bank stock falls 4% after 7.9% stake worth \u20b9 1,100 Cr changed hands&#8221; &#8212; Trade Brains\" src=\"https:\/\/tradebrains.in\/features\/block-deal-bank-stock-falls-4-after-7-9-stake-worth-1100-cr-changed-hands\/embed\/#?secret=5RMFJ5vwgx#?secret=otBllmPg3H\" data-secret=\"otBllmPg3H\" width=\"600\" height=\"338\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\n<\/div><\/figure><p>Both companies will license specific brands to the new entity, with Nestl\u00e9 contributing popular brands like Nature&#8217;s Bounty and Osteo Bi-Flex, while Dr. Reddy&#8217;s will provide brands such as Rebalanz and Celevida.&nbsp;<\/p><p>The joint venture entity will have its headquarters in Hyderabad and is anticipated to commence operations in the second quarter of FY25. Its primary objective will be to enhance and broaden synergistic nutraceutical offerings across various categories, including metabolic care, hospital nutrition, general wellness, women&#8217;s health, and child nutrition.&nbsp;<\/p><div class=\"trade-content-10\" id=\"trade-3852027104\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financials<\/strong><strong>&nbsp;<\/strong><\/h2><p>In the quarter ending March 2024, Dr. Reddy\u2019s Laboratories saw its revenue rise significantly by 24.5 percent to Rs.5,081.8 crores compared to the previous quarter. The company&#8217;s <strong>Profit After Tax (PAT) also experienced a substantial increase, jumping 118 percent <\/strong>to Rs.1,034.8 crores from Q3 FY24.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the company<\/strong><strong>&nbsp;<\/strong><\/h2><p>Dr. Reddy&#8217;s Laboratories is an Indian multinational pharmaceutical company that manufactures and markets a wide range of pharmaceuticals in India and overseas. The company manufactures and markets generic formulations, active pharmaceutical ingredients (APIs), biosimilars, and proprietary products.&nbsp;<\/p><p><strong>Written by &#8211; Siddesh S Raskar&nbsp;<\/strong><\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Disclaimer<\/strong><\/h2><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-1938328857\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Share price of a leading pharmaceutical company rose by nearly 1 percent following its announcement of plans for a stock split and a joint venture with Nestle.\u00a0 Price movement&nbsp; In Thursday\u2019s trading session, the share price of Dr. Reddy\u2019s Laboratories Ltd. reached an intra-day high of Rs.6,853 per share gaining nearly 1 percent after opening [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":24277,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[20842,20844,20841,20843,948,936],"class_list":["post-129454","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-dr-reddys-latest-news","tag-dr-reddys-partnership-with-nestle","tag-dr-reddys-share-price-3","tag-dr-reddys-stock-split","tag-stock-market","tag-stock-market-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps after it announces stock split and JV with Nestle - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Share price of a leading pharmaceutical company rose by nearly 1 percent following its announcement of plans for a stock split and a joint venture with Nestle.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps after it announces stock split and JV with Nestle\" \/>\n<meta property=\"og:description\" content=\"Share price of a leading pharmaceutical company rose by nearly 1 percent following its announcement of plans for a stock split and a joint venture with Nestle.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-25T09:37:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-25T09:42:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/Nestle-Cover-Image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/\",\"name\":\"Pharma stock jumps after it announces stock split and JV with Nestle - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/Nestle-Cover-Image.jpg\",\"datePublished\":\"2024-07-25T09:37:30+00:00\",\"dateModified\":\"2024-07-25T09:42:56+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Share price of a leading pharmaceutical company rose by nearly 1 percent following its announcement of plans for a stock split and a joint venture with Nestle.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/Nestle-Cover-Image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/Nestle-Cover-Image.jpg\",\"width\":1280,\"height\":854,\"caption\":\"Nestle - Cover Image\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps after it announces stock split and JV with Nestle\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps after it announces stock split and JV with Nestle - Trade Brains Features","description":"Share price of a leading pharmaceutical company rose by nearly 1 percent following its announcement of plans for a stock split and a joint venture with Nestle.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps after it announces stock split and JV with Nestle","og_description":"Share price of a leading pharmaceutical company rose by nearly 1 percent following its announcement of plans for a stock split and a joint venture with Nestle.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-07-25T09:37:30+00:00","article_modified_time":"2024-07-25T09:42:56+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/Nestle-Cover-Image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/","name":"Pharma stock jumps after it announces stock split and JV with Nestle - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/Nestle-Cover-Image.jpg","datePublished":"2024-07-25T09:37:30+00:00","dateModified":"2024-07-25T09:42:56+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Share price of a leading pharmaceutical company rose by nearly 1 percent following its announcement of plans for a stock split and a joint venture with Nestle.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/Nestle-Cover-Image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/Nestle-Cover-Image.jpg","width":1280,"height":854,"caption":"Nestle - Cover Image"},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-after-it-announces-stock-split-and-jv-with-nestle\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps after it announces stock split and JV with Nestle"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/129454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=129454"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/129454\/revisions"}],"predecessor-version":[{"id":129457,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/129454\/revisions\/129457"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/24277"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=129454"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=129454"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=129454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}